Summit Global Investments Simulations Plus, Inc. Transaction History

Summit Global Investments

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 08, 2021	SELL	$38.45 - $55.66 $1 Million - $1.45 Million	-26,100 Closed	0 $0
Q2 2021 Jan 28, 2022	BUY	$49.67 - $68.96 $712,069 - $988,610	14,336 Added 121.86%	26,100 $1.43 Million
Q1 2021 Jan 27, 2022	SELL	$60.06 - $89.52 $192,372 - $286,732	-3,203 Reduced 21.4%	11,764 $744,000
Q4 2020 Feb 11, 2021	SELL	$53.26 - $77.18 $689,610 - $999,326	-12,948 Reduced 46.38%	14,967 $1.08 Million
Q3 2020 Nov 16, 2020	BUY	$57.51 - $75.36 $81,376 - $106,634	1,415 Added 5.34%	27,915 $2.1 Million
Q2 2020 Aug 11, 2020	BUY	$32.91 - $59.82 $23,036 - $41,874	700 Added 2.71%	26,500 $1.59 Million
Q1 2020 May 14, 2020	BUY	$26.79 - $38.99 $691,182 - $1.01 Million	25,800 New	25,800 $901,000

175

15.1M

5.4K

1.4K

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $582M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

Stay updated on Summit Global Investments with notifications on news.